Jump to content


Hang onto your hat: Sclero Forums Upgrade May 14-21, 2017!! The Forums will be offline for up to 4 days, and then will return with an entirely new look and feel.


Photo

Low bone mass in juvenile onset sclerosis systemic (JoSSc): the possible role for 25-hydroxyvitamin D (250HD) insufficiency.


  • Please log in to reply
No replies to this topic

#1 Jeannie McClelland

Jeannie McClelland

    Senior Gold Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 1,696 posts
  • Location:in the Rocky Mountains of the USA

Posted 15 April 2010 - 10:42 AM

Low bone mass in juvenile onset sclerosis systemic (JoSSc): the possible role for 25-hydroxyvitamin D (250HD) insufficiency. We have identified a remarkable high prevalence of 25OHD insufficiency in JoSSc. Its correlation with hip bone mineral apparent density (BMAD) suggests a causal effect and reinforces the need to incorporate this hormone evaluation in this disease management. Samuel Katsuyuki Shinjo (SpringerLink) Rheumatology International 25 March 2010. (Also see: Juvenile Scleroderma and Vitamin D)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Jeannie McClelland
(Retired) ISN Director of Support Services
(Retired) ISN Sclero Forums Manager
(Retired) ISN Blog Manager
(Retired) ISN Assistant News Guide
(Retired) ISN Artist
International Scleroderma Network